Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial. [electronic resource]
Producer: 20140930Description: 1410-5 p. digitalISSN:- 1468-3288
- Adult
- Aged
- Amoxicillin -- therapeutic use
- Antacids -- therapeutic use
- Anti-Bacterial Agents -- therapeutic use
- Anti-Ulcer Agents -- therapeutic use
- Asian People
- Breath Tests
- China
- Clarithromycin -- therapeutic use
- Cross-Over Studies
- Drug Administration Schedule
- Drug Therapy, Combination
- Esomeprazole -- therapeutic use
- Female
- Follow-Up Studies
- Helicobacter Infections -- diagnosis
- Helicobacter pylori
- Humans
- Intention to Treat Analysis
- Male
- Metronidazole -- therapeutic use
- Middle Aged
- Organometallic Compounds -- therapeutic use
- Prospective Studies
- Tetracycline -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.